Discovery of potent and orally bioavailable degraders of HPK1 based on a novel HPK1 binder

被引：0
|
作者：
Zhang, Zhimin
Wu, Mengqiang
Wang, Ling
Yang, Xi
Zhang, Zhiping
Guo, Liubin
Pan, Hao
Zhao, Mengting
Wang, Linli
Liu, Sirui
Dong, Zhao
Jiang, Chunhua
Zheng, Haowen
Liu, Dongzhou
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4514
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation
    Johnson, Eric
    McTigue, Michele
    Gallego, Rebecca A.
    Johnson, Ted W.
    Timofeevski, Sergei
    Maestre, Michael
    Fisher, Timothy S.
    Kania, Robert
    Sawasdikosol, Sansana
    Burakoff, Steven
    Cronin, Ciaran N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (23) : 9029 - 9036
  • [22] Discovery of Pyridine-2-Carboxamides Derivatives as Potent and Selective HPK1 Inhibitors for the Treatment of Cancer
    Peng, Jingjing
    Ding, Xiaoyu
    Chen, Celia Xiaojing
    Zhao, Pei
    Ding, Xiao
    Zhang, Man
    Aliper, Alex
    Ren, Feng
    Lu, Hongfu
    Zhavoronkov, Alex
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 21520 - 21544
  • [23] Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds
    Vara, Brandon A.
    Levi, Samuel M.
    Achab, Abdelghani
    Candito, David A.
    Fradera, Xavier
    Lesburg, Charles A.
    Kawamura, Shuhei
    Lacey, Brian M.
    Lim, Jongwon
    Methot, Joey L.
    Xu, Zangwei
    Xu, Haiyan
    Smith, Dustin M.
    Piesvaux, Jennifer A.
    Miller, J. Richard
    Bittinger, Mark
    Ranganath, Sheila H.
    Bennett, David J.
    DiMauro, Erin F.
    Pasternak, Alexander
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (04): : 653 - 661
  • [24] Development and characterization of small molecule HPK1 inhibitors.
    Kujawa, Maciej
    Zimolag, Eliza
    Galezowski, Michal
    Guzik, Pawel
    Dudek, Agata
    Gondela, Andrzej
    Nowogrodzki, Marcin
    Girardi, Marianna
    Krolenko, Kostiantyn
    Bugaj, Marta
    Sudol, Sylwia
    Gibas, Agnieszka
    Szeremeta-Spisak, Joanna
    Bobowska, Aneta
    Zastawna, Magdalena
    Wyrebek, Przemyslaw
    Boutard, Nicolas
    Wieckowska, Aleksandra
    Jasnosz, Wojciech
    Schonemann, Wojciech
    Zuchowicz, Karol
    Synak, David
    Kulesza, Urszula
    Leventes, Oleksandr
    Swirski, Mateusz
    Sasmal, Sujit
    Gluza, Karolina
    Kret, Patryk
    Ogorek, Mateusz
    Michalik, Kinga
    Banaszak, Katarzyna
    Podkowa, Adrian
    Wnuk-Lipinska, Katarzyna
    Dobrzanska, Monika
    Littlewood, Peter
    Brzozka, Krzysztof
    Bartosik, Anna
    Chmielewski, Stefan
    CANCER RESEARCH, 2021, 81 (13)
  • [25] Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor
    Shields, Jason D.
    Baker, David
    Balazs, Amber Y. S.
    Bommakanti, Gayathri
    Casella, Robert
    Cao, Shenggen
    Cook, Steve
    Escobar, Randolph A.
    Fawell, Stephen
    Gibbons, Francis D.
    Giblin, Kathryn A.
    Goldberg, Frederick W.
    Gosselin, Eric
    Grebe, Tyler
    Hariparsad, Niresh
    Hatoum-Mokdad, Holia
    Howells, Rachel
    Hughes, Samantha J.
    Jackson, Anne
    Reddy, Iswarya Karapa
    Kettle, Jason G.
    Lamont, Gillian M.
    Lamont, Scott
    Li, Min
    Lill, Sten O. Nilsson
    Mele, Deanna A.
    Metrano, Anthony J.
    Mfuh, Adelphe M.
    Morrill, Lucas A.
    Peng, Bo
    Pflug, Alexander
    Proia, Theresa A.
    Rezaei, Hadi
    Richards, Ryan
    Richter, Magdalena
    Robbins, Kevin J.
    San Martin, Maryann
    Schimpl, Marianne
    Schuller, Alwin G.
    Sha, Li
    Shen, Minhui
    Sheppeck, James E.
    Singh, Meha
    Stokes, Stephen
    Song, Kun
    Sun, Yuanyuan
    Tang, Haoran
    Wagner, David J.
    Wang, Jianyan
    Wang, Yanjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (04) : 4582 - 4595
  • [26] Updated patent review for hematopoietic progenitor kinase (HPK1) inhibitors and degraders (2021-present)
    Yuan, Ying-Hui
    Mao, Jia-Ying
    Yue, Ji-Fan
    He, Meng-Lan
    Hui, Zi
    Yin, Hang
    Wang, Jianshe
    Ye, Xiang-Yang
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 35 (04) : 387 - 408
  • [27] NOVEL, ORALLY ADMINISTERED HPK1 INHIBITORS DEMONSTRATE ANTI-TUMOR EFFICACY AND ENHANCED IMMUNE RESPONSE
    Chmielewski, Stefan
    Kujawa, Maciej
    Zimolag, Eliza
    Galezowski, Michal
    Gondela, Andrzej
    Guzik, Pawel
    Dudek, Agata
    Szeremeta-Spisak, Joanna
    Bugaj, Marta
    Levenets, Iana
    Nowogrodzki, Marcin
    Girardi, Marianna
    Zagorska, Anna
    Wyrebek, Przemyslaw
    Zastawna, Magdalena
    Gibas, Agnieszka
    Sudol, Sylwia
    Levenets, Oleksandr
    Swirski, Mateusz
    Sasmal, Sujit
    Radzimierski, Adam
    Sowinska, Marta
    Niedziejko, Paulina
    Zuchowicz, Karol
    Swarbrick, Martin
    Gluza, Karolina
    Kret, Patryk
    Ogorek, Mateusz
    Stanko, Dominika
    Michalik, Kinga
    Piatek, Agnieszka
    Banaszak, Katarzyna
    Podkowa, Adrian
    Golas, Aniela
    Littlewood, Peter
    Brzozka, Krzysztof
    Chielewski, Stefan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A786 - A786
  • [28] HZ-S506, A SELECTIVE AND ORALLY BIOAVAILABLE HPK1 DEGRADER, IS EFFICACIOUS AS A SINGLE AGENT OR IN COMBINATION WITH PD-1 ANTIBODY
    Wu, Yizhe
    Zhou, Xinglu
    Jin, Tingting
    Jin, Xinxin
    Wu, Yizhe
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1149 - A1149
  • [29] Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress
    Chen, Hui
    Guan, Xiangna
    He, Chi
    Lu, Tingting
    Lin, Xingyu
    Liao, Xuebin
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2024, 28 (04) : 237 - 250
  • [30] The development of small-molecule inhibitors targeting HPK1
    Zhou, Lixin
    Wang, Tianyu
    Zhang, Kuojun
    Zhang, Xiangyu
    Jiang, Sheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
12345